Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD
for Attention-Deficit/Hyperactivity Disorder
47 locations incl. Saraland
Sponsor: Supernus Pharmaceuticals, Inc.
Sex: All·Age: 48 Months - 69 Months
Code: NCT04781140·Phase 4·Recruiting